🔎 Trials Near Me

Akèy › Kadyomiopati › Distrik Columbia

Etid klinik pou Kadyomiopati nan Distrik Columbia

7 etid pou Kadyomiopati ap chèche patisipan nan sit nan Distrik Columbia.

Vil nan Distrik Columbia

Tèks ofisyèl etid la (Anglè)

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

  • Hope Center, Washington D.C.
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 1 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01143454

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Washington D.C.
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • MedStar Washington Hospital Center - MedStar Heart and Vascular Institute, Washington D.C.
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

  • Children's National, Washington D.C.
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 28, 2026 · NCT07674758

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

  • Medstar Washington Hospital Center, Washington D.C.
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05034432

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • MedStar Washington Hospital Center - MedStar Heart and Vascular Institute, Washington D.C.
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

  • Washington Hospital Center, Washington D.C.
Ap rekriteEtid obsèvasyon
Laj 18 a 85 · Tout sèks · Mizajou Jan 20, 2026 · NCT00733590

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.